CMS issues final rule for Medicaid demonstration

The Centers for Medicare & Medicaid Services has issued a final rule on procedures states must follow when running Medicaid demonstration projects.

The final rule is meant to increase public input while letting states test new coverage and delivery models. It applies to applications for new demonstration projects and extensions for existing projects.

In addition to requiring CMS to initiate a public comment period after a state submits an application, the rule requires states to publish notice of the demonstration application on its Medicaid website and in newspapers.

That notice must include:

• a comprehensive description of the demonstration project application or extension;

• the goals and objectives to be implemented under the demonstration project;

• the proposed healthcare delivery system and eligibility requirements for individuals affected by the demonstration project; and

• an estimate of the expected increase or decrease in annual enrollment and in aggregate expenditures as a result of the demonstration project.

Click here to read the final rule.

More in News

Experts tell lawmakers: Obama Medicare proposals would hurt long-term care — or maybe not

Experts tell lawmakers: Obama Medicare proposals would hurt ...

U.S. lawmakers heard mixed messages at a hearing Tuesday on how proposed Medicare cost-sharing reforms would impact long-term care. The House Ways and Means Subcommittee on Health focused in particular ...

Nursing home administrators can rise to 'unrealistic expectations' with disaster management, expert ...

One day after a powerful tornado destroyed a hospital and devastated an Oklahoma town, long-term care stakeholders gathered at a disaster preparedness conference organized by the Center for Preparedness Education, a joint endeavor of the Creighton University School of Medicine and the University of Nebraska ...

Long-term care physicians respond to report on antipsychotic over-prescribing

The top professional association of long-term care physicians and medical directors has reiterated its commitment to reducing the use of antipsychotics for dementia care. It did so Tuesday, in response to a recent report that criticized prescribing practices.